P. Horal

发表

Activity of the Small Modified Amino Acid α-Hydroxy Glycineamide on In Vitro and In Vivo Human Immunodeficiency Virus Type 1 Capsid Assembly and Infectivity

S. Höglund, Á. Végvári, E. Andersson, 2008, Antimicrobial Agents and Chemotherapy.

No cross-resistance or selection of HIV-1 resistant mutants in vitro to the antiretroviral tripeptide glycyl-prolyl-glycine-amide.

E. Andersson, B. Svennerholm, A. Vahlne, 2004, Antiviral research.

N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity.

A. Sjölander, S. Olofsson, S. Sjölander, 1996, Virology.

Identification of cross-reactive antigenic target regions for HIV type 1-specific antibody-dependent cellular cytotoxicity.

B. Wahrén, B. Svennerholm, A. Vahlne, 1996, AIDS research and human retroviruses.

Combined Testing of p16 Tumour-suppressor Protein and Human Papillomavirus in Patients With Oral Leukoplakia and Oral Squamous Cell Carcinoma

J. Hirsch, E. Holmberg, M. Lindh, 2019, AntiCancer Research.

Predictive factors and virological response to interferon treatment in children with chronic hepatitis B

N. Conradi, G. Norkrans, M. Lindh, 2005, Scandinavian journal of infectious diseases.

Histologic Activity of Childhood Chronic Hepatitis B Related to Viremia Levels, Genotypes, Mutations, and Epidemiologic Factors

N. Conradi, G. Norkrans, M. Lindh, 2002, Journal of pediatric gastroenterology and nutrition.

Long-term mutation rates in the hepatitis B virus genome.

C. Hannoun, M. Lindh, P. Horal, 2000, The Journal of general virology.

Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers.

C. Hannoun, G. Norkrans, M. Lindh, 1999, The Journal of infectious diseases.

HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B.

G. Norkrans, K. Savage, M. Lindh, 1999, Liver.

Mutation of nucleotide 1,762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriers

G. Norkrans, M. Lindh, A. Dhillon, 1998, Journal of medical virology.

Hepatitis B virus carriers without precore mutations in hepatitis B e antigen‐negative stage show more severe liver damage

A. Dhillon, G. Norkrans, M. Lindh, 1996, Hepatology.

Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120.

C. Czerkinsky, J. Holmgren, B. Svennerholm, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Outbreak of norovirus in Västra Götaland associated with recreational activities at two lakes during August 2004

B. Sartorius, K. Hedlund, B. de Jong, 2007, Scandinavian journal of infectious diseases.

Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates

W. Hall, B. Svennerholm, A. Vahlne, 1991, Journal of virology.

Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2

Gustaf E. Rydell, A. Martner, K. Hellstrand, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Virological response to interferon therapy of chronic hepatitis B as measured by a highly sensitive assay

C. Hannoun, M. Lindh, K. Krogsgaard, 2001, Journal of viral hepatitis.

Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon.

G. Norkrans, M. Lindh, P. Horal, 1998, Journal of virological methods.

Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.

D. Smadja, A. Vahlne, C. Desgranges, 1994, AIDS research and human retroviruses.

Glycine-Amide Is an Active Metabolite of the Antiretroviral Tripeptide Glycyl-Prolyl-Glycine-Amide

S. Höglund, E. Andersson, J. Balzarini, 2005, Antimicrobial Agents and Chemotherapy.

Inhibition of herpes simplex virus production in vitro by Cyclosporin A

B. Svennerholm, A. Vahlne, S. Olofsson, 2005, Archives of Virology.

Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).

P. Proost, E. Andersson, J. Van Damme, 2004, The international journal of biochemistry & cell biology.

HIV type 1 V3 sequence diversity in contact-traced Swedish couples at the time of sexual transmission.

G. Norkrans, T. Bergström, Y. Furuta, 1994, AIDS research and human retroviruses.

Emergence of precore TAG mutation during hepatitis B e seroconversion and its dependence on pregenomic base pairing between nucleotides 1858 of 1896.

G. Norkrans, A. Vahlne, M. Lindh, 1995, The Journal of infectious diseases.

Tracing of Norovirus Outbreak Strains in Mussels Collected near Sewage Effluents

C. Hannoun, T. Bergström, B. Hernroth, 2008, Applied and Environmental Microbiology.

Real-time Taqman PCR targeting 14 human papilloma virus types.

E. Andersson, M. Lindh, W. Ryd, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Neurovirulence of herpes simplex virus types 1 and 2 isolates in diseases of the central nervous system

K. Alestig, B. Svennerholm, A. Vahlne, 1990, European Journal of Clinical Microbiology and Infectious Diseases.

Genotype Mixtures of Hepatitis B Virus in Patients Treated with Interferon

C. Hannoun, M. Lindh, K. Krogsgaard, 2002 .

Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection.

M. Lindh, P. Horal, U. Noborg, 2000, Scandinavian journal of infectious diseases.

Mutations in the X region and core promoter are rare and have little impact on response to interferon therapy for chronic hepatitis B

C. Hannoun, M. Lindh, K. Krogsgaard, 2002, Journal of medical virology.

Detection of hepatitis B virus precore TAG mutant by an amplification-created restriction site method.

G. Norkrans, M. Lindh, Y. Furuta, 1995, The Journal of infectious diseases.

Genotype mixtures of hepatitis B virus in patients treated with interferon.

C. Hannoun, M. Lindh, K. Krogsgaard, 2002, The Journal of infectious diseases.

Phylogenetic Origin of Hepatitis B Virus Strains with Precore C-1858 Variant

C. Hannoun, M. Lindh, P. Horal, 2001, Journal of Clinical Microbiology.

Hepatitis B virus genotypes in Mongols and Australian Aborigines

C. Hannoun, M. Lindh, P. Horal, 2001, Archives of Virology.

Chronic hepatitis B in children in Gothenburg, Sweden.

G. Norkrans, M. Lindh, M. Krantz, 1999, Scandinavian journal of infectious diseases.

Acute Hepatitis B in Western Sweden – Genotypes and Transmission Routes

G. Norkrans, M. Lindh, P. Horal, 2000, Infection.

Are adjunctive markers useful in routine cervical cancer screening? Application of p16INK4a and HPV‐PCR on ThinPrep samples with histological follow‐up

M. Lindh, W. Ryd, P. Horal, 2008, Diagnostic cytopathology.

The polymorphism of MSTN, PRNP and CSN3 genes in Charolais cattle

T. Szulc, A. Filistowicz, P. Horal, 2002 .

Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.

E. Andersson, M. Lindh, W. Ryd, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Type-Specific Human Papillomavirus E6/E7 mRNA Detection by Real-Time PCR Improves Identification of Cervical Neoplasia

E. Andersson, M. Lindh, W. Ryd, 2011, Journal of Clinical Microbiology.

Systematic identification of T-cell activating epitopes on the human immunodeficiency virus type 1 envelope glycoprotein gp120 in primates immunized with synthetic peptides.

C. Czerkinsky, B. Svennerholm, A. Vahlne, 1993, Vaccine.

Characterization of monoclonal antibodies against the p17 core protein of the human immunodeficiency virus 1.

A. Vahlne, N. De Schepper, P. Horal, 1990, Journal of immunological methods.

Human T-Cell Lymphotropic Virus Type 1 Gag Indeterminate Western Blot Patterns in Central Africa: Relationship toPlasmodium falciparum Infection

E. Murphy, R. Mahieux, A. Gessain, 2000, Journal of Clinical Microbiology.

Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.

E. Murphy, R. Mahieux, A. Gessain, 2000, Journal of clinical microbiology.

Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.

M. Kaplan, W. Hall, B. Svennerholm, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Identification of exposed epitopes on the envelope glycoproteins of human T‐cell lymphotropic virus type I (HTLV‐I)

A. Rosenberg, C. Desgranges, P. Horal, 1998, International journal of cancer.

Possible association of HTLV‐I infection and dementia

B. Svennerholm, A. Svenningsson, O. Andersen, 1993, Acta neurologica Scandinavica.

Use of immunoreactive synthetic HTLV‐1 peptides in the search for antibody reactivity in multiple sclerosis

E. Ben-Menachem, B. Svennerholm, A. Vahlne, 1992, Acta neurologica Scandinavica.

Amplified ELISPOT assay for the detection of HIV-specific antibody-secreting cells in subhuman primates.

C. Czerkinsky, J. Holmgren, B. Svennerholm, 1992, Journal of immunological methods.

Discrimination of herpes simplex virus types 1 and 2 cerebral infections in a rat model

N. Conradi, B. Svennerholm, A. Vahlne, 2004, Acta Neuropathologica.

Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.

C. Czerkinsky, J. Holmgren, B. Svennerholm, 1991, Proceedings of the National Academy of Sciences of the United States of America.

High-risk human papillomavirus in patients with oral leukoplakia and oral squamous cell carcinoma - A multi-centre study in Sweden, Brazil and Romania.

J. Hirsch, M. Lindh, M. Hinescu, 2020, Oral diseases.

Brush Samples of Oral Lesions to FTA Elute Card for High-risk Human Papilloma Virus Diagnosis

J. Hirsch, U. Gyllensten, I. Gustavsson, 2021, Anticancer Research.

Humoral immunity to tetanus, diphtheria and polio in adults after treatment for hematological malignancies.

P. Ljungman, T. Bergström, B. Kaijser, 2019, Vaccine.

Type-Speciﬁc Human Papillomavirus E6/E7 mRNA Detection by Real-Time PCR Improves Identiﬁcation of Cervical Neoplasia (cid:1)

E. Andersson, L. Blomqvist, M. Lindh, 2011 .

Identification of type-specific linear epitopes in the glycoproteins gp 46 and gp 2 l of human T-cell leukemia viruses type I and type II using synthetic peptides ( specific antibody detection )

B. Svennerholm, A. Vahlne, S. Jeansson, 2022 .

The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1.

M. Naghavi, B. Svennerholm, A. Vahlne, 2001, Journal of human virology.

Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B

G. Norkrans, A. Dhillon, M. Lindh, 2000, Journal of viral hepatitis.

Prevalence of HIV‐1 infection in rural, semi‐urban and urban villages in southwest Tanzania: estimates from a blood‐donor study

A. Vahlne, P. Horal, B. Ekstedt, 1994, AIDS.